Europe Tumor Ablation Market Report and Forecast 2024-2032

Europe Tumor Ablation Market Outlook

The Europe tumor ablation market size was valued at USD 0.3 billion in 2023, driven by the rising preference for minimally invasive treatment procedures in the region. The market is expected to grow at a CAGR of 12.92% during the forecast period of 2024-2032, with the values likely to rise from USD 0.4 billion in 2024 to USD 0.9 billion by 2032.

Key Takeaways

• In December 2023, Clinical Laserthermia Systems (CLS) participated in IRMPROFT (a research study) with its TRANBERG system, a cutting-edge solution for minimally invasive, image-guided focal laser ablation aimed at treating cancer. The application of tumor ablation with combination therapies is projected to increase the Europe tumor ablation market growth in the forecast period.

• The market is affected by the rising number of FDA approvals for new tumor ablation systems, including Medtronic receiving a 510(k) clearance for OsteoCool™ 2.0, their new tumor ablation system.

• Cancer is the fourth most common cause of death in Europe, causing the tumor ablation market to keep expanding with innovations and technological advancements.

Europe Tumor Ablation Market Analysis

Tumor ablation is a minimally invasive procedure that uses extreme heat or cold to shrink or destroy tumors. It involves inserting a needle-tipped catheter into the tumor with the help of imaging guidance. The technological advancements along with the innovation of new procedures are expected to generate profitable opportunities, thereby, contributing to increased Europe tumor ablation market share.

The rising geriatric population and growing prevalence of cancer cases are amongst some of the most influential factors responsible for driving the growth of the market. After cardiovascular diseases, cancer is the most common cause of death and morbidity in Europe accounting for more than 3.7 million new cases and 1.9 million deaths each year in Europe. The market is also experiencing significant traction due to the rising demand for minimally invasive treatments and increasing awareness about ablation procedures, propelling the heightening of the Europe tumor ablation market demand.

In March 2024, Medtronic plc received U.S. Food and Drug Administration (FDA) 510(k) clearance for its OsteoCool™ 2.0 bone tumor ablation system for the treatment of painful bone metastases and benign bone tumors such as osteoid osteoma. Integrated with several new features OsteoCool is poised to bring innovation to the market. Portfolio expansions by market players are expected to influence the Europe tumor ablation market size in the coming years. 

The market is further influenced by the increasing number of research activities, and efforts of key players towards expanding their global footprint as well as enhance the existing technologies present in the market. In December 2023, Clinical Laserthermia Systems (CLS) announced participation in a new research study, called IRMPROFT, to examine the use of MRI in combination with biopsies to diagnose residual prostate cancer post-focal therapy. The company is participating in this study with their TRANBERG system, a cutting-edge solution for minimally invasive, image-guided focal laser ablation aimed at treating cancer. The application of tumor ablation in combination with other therapies is poised to drive market growth in the forecast period.

Europe Tumor Ablation Market Segmentation

The report offers a detailed analysis of the market based on the following segments:

Europe Tumor Ablation Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

• EDAP TMS

• Mermaid Medical

• BVM Medical Limited

• Cortex Technology

• Olympus Corporation

• BIOTRONIK SE & Co KG

• Boston Scientific Corporation

• Medtronic plc

• AngioDynamics, Inc.

• Merit Medical Systems, Inc.

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Highlights of the Report

Europe Tumor Ablation Market Report Snapshots

Europe Tumor Ablation Market Size

Europe Tumor Ablation Market Analysis

Europe Tumor Ablation Companies